Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nyse  >  Boston Scientific Corporation    BSX

BOSTON SCIENTIFIC CORPORATION (BSX)
Mes dernières consult.
Most popular
  Report  
 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nyse
07/12/2018 07/13/2018 07/16/2018 07/17/2018 07/18/2018 Date
33.34(c) 33.35(c) 33.15(c) 33.95(c) 33.74(c) Last
4 704 227 4 994 380 7 234 801 8 800 409 6 429 717 Volume
0.00% +0.03% -0.60% +2.41% -0.62% Change
More quotes
Financials (USD)
Sales 2018 9 820 M
EBIT 2018 2 508 M
Net income 2018 1 344 M
Debt 2018 4 475 M
Yield 2018 -
Sales 2019 10 464 M
EBIT 2019 2 824 M
Net income 2019 1 660 M
Debt 2019 3 500 M
Yield 2019 -
P/E ratio 2018 35,23
P/E ratio 2019 29,04
EV / Sales2018 5,23x
EV / Sales2019 4,81x
Capitalization 46 845 M
More Financials
Company
Boston Scientific Corp. engages in the development, manufacture and marketing of medical devices that are used in interventional medical specialties.It operates through the following segments: Cardiovascular, Rhythm Management, and MedSurg.The Cardiovascular segment comprises of technologies or... 
More about the company
Surperformance© ratings of Boston Scientific Corporat
Trading Rating : Investor Rating :
More Ratings
Latest news on BOSTON SCIENTIFIC CORPORAT
07/13BOSTON SCIENTIFIC : $117,400 Federal Contract Awarded to Boston Scientific
AQ
07/12BOSTON SCIENTIFIC : An Application for the Trademark "VERCISE GENUS" Has Been Fi..
AQ
07/10BOSTON SCIENTIFIC CORPORATION : Report
CO
07/09BOSTON SCIENTIFIC : to Buy Remaining Stake in Cryoablation Platform Developer
AQ
07/06BOSTON SCIENTIFIC : to pay $202 million to acquire Cryterion Medical
AQ
07/05BOSTON SCIENTIFIC : An Application for the Trademark "SYNERGY MEGATRON" Has Been..
AQ
07/05BOSTON SCIENTIFIC : FEops Strengthens Management Team
AQ
07/05BOSTON SCIENTIFIC : to Acquire Cryterion Medical, Inc.
PR
07/02BOSTON SCIENTIFIC : Announces Conference Call Discussing Second Quarter 2018 Fin..
PR
06/30BOSTON SCIENTIFIC : Federal Contracts Awarded by Federal Agencies in Iowa (June ..
AQ
More news
Sector news : Advanced Medical Equipment & Technology - NEC
07/12ROYAL PHILIPS : Philips Signs Long-Term Partnerships Worth EUR140 Million
DJ
07/11Brazil prosecutors allege jailed GE executive helped company partake in medic..
RE
07/06Correction to Tariffs Shock Waves Article on Thursday
DJ
07/06ROYAL PHILIPS : Philips to set aside $35 million for potential EU price-fixing f..
RE
07/05Even Before Tariffs Hit, Shock Waves Ripple Through World Economy -- 2nd Upda..
DJ
More sector news : Advanced Medical Equipment & Technology - NEC
4-Traders Strategies on BOSTON SCIENTIFIC CORPORAT 
BOSTON SCIENTIFIC CORPORATION - 2012
All technical elements to short
SELL
More Strategies
Latest Tweets
01:15aInvestors Buy Shares of Boston Scientific $BSX on Weakness  
07/18$HLT Aug 85 calls EPS 7/25 Suntrust reiterated BUY & $95 target $FTI Jul..
1
07/1860 Second Video from investitute $UAL $MS $KLAC $AMAT $LCRX $CLX $GS $TWTR $.. 
07/1860 Second Video with actionable ideas for those that actualy trade vs navel g..
5
07/18I didn't expect GE or tiny medical-device maker Neovasc to be some of the mos..
3
More tweets
Qtime:123
News from SeekingAlpha
07/17Boston Scientific Is A Solid Buy Opportunity In 2018 
07/11High Expectations Could Be Teleflex's Most Serious Challenge 
07/06Med devices group joins broad rally 
07/05Healthcare Dashboard - Update 
07/05Boston Scientific may see modest sales bump from Cryterion in three years or .. 
Chart BOSTON SCIENTIFIC CORPORAT
Duration : Period :
Boston Scientific Corporat Technical Analysis Chart | BSX | US1011371077 | 4-Traders
Technical analysis trends BOSTON SCIENTIFIC CORPORAT
Short TermMid-TermLong Term
TrendsNeutralBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 24
Average target price 34,9 $
Spread / Average Target 2,8%
EPS Revisions
Managers
NameTitle
Michael F. Mahoney Chairman, President & Chief Executive Officer
John Bradley Sorenson Senior Vice President-Manufacturing & Supply Chain
Edward Mackey Executive Vice President-Operations
Daniel J. Brennan Chief Financial Officer & Executive Vice President
Ian T. Meredith Global Chief Medical Officer & Executive VP
Sector and Competitors
1st jan.Capitalization (M$)
BOSTON SCIENTIFIC CORPORATION36.95%46 845
THERMO FISHER SCIENTIFIC11.14%84 906
DANAHER CORPORATION7.28%69 564
INTUITIVE SURGICAL43.53%59 342
ILLUMINA38.22%44 907
ROYAL PHILIPS18.26%40 841